Results 81 to 90 of about 41,151 (199)

The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteers. [PDF]

, 1991
DR Robertson, Irene J Higginson, BS Macklin, AG Renwick, DG Waller, CF George   +5 more
openalex   +1 more source

Comparing Parkinson's Disease Medications Categorised by Location in New South Wales, Australia: Linking the 45 and Up Study and the Pharmaceutical Benefits Scheme (PBS) Data. [PDF]

Aust J Rural Health
Logan PA, Micalos PS, Fealy S, Bramble M, Wong A.   +4 more
europepmc   +1 more source

Disposition of gamma‐glutamyl levodopa (gludopa) after intravenous bolus injection in healthy volunteers. [PDF]

, 1991
YA Boateng, HE Barber, Thomas M. MacDonald, JC Petrie, MR Lee   +4 more
openalex   +1 more source

An In Vitro-In Vivo Comparison of Two Levodopa Dry Powder Products for Inhalation: A Randomized Trial Comparing Inbrija and Levodopa Cyclops. [PDF]

Pharmaceutics
Berends JME, Wimmenhove EJ, Hoppentocht M, Hagedoorn P, Frijlink HW, Grasmeijer F.   +5 more
europepmc   +1 more source

Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's disease. [PDF]

, 1991
M. Maral Mouradian, Isabella J.E. Heuser, Fabio Baronti, Marianne Giuffra, Kathy Conant, Thomas L. Davis, Thomas N. Chase   +6 more
openalex   +1 more source

The Cost-Effectiveness of Opicapone Versus Entacapone as Adjuvant Therapy for Levodopa-Treated Individuals With Parkinson's Disease Experiencing End-of-Dose Motor Fluctuations. [PDF]

Parkinsons Dis
Harrison-Jones G, Green W, Bainbridge J.
europepmc   +1 more source

Understanding the progression of Parkinson's disease: a review. [PDF]

BMJ Neurol Open
Kempster PA.
europepmc   +1 more source

Dopamine receptor D1-mediated suppression of liver fibrosis <i>via</i> Hippo/Yes-associated protein 1 signaling in levodopa treatment. [PDF]

World J Gastroenterol
Wang HY, Qi MM, Zhang K, Zhu YZ, Zhang J.   +4 more
europepmc   +1 more source

Levodopa/Dopamine Analogs as Inhibitors of DNA Synthesis in Human Melanoma Cells

, 1989
Michael M. Wick
openalex   +1 more source

Levodopa-Carbidopa-Entacapone Intestinal Gel for Advanced Parkinson's Disease-Results from a Monocentric Study Evaluating Both Motor and Non-Motor Manifestations. [PDF]

Biomedicines
Lungu M, Oprea VD, Apostol LL, Elkan EM, Ionescu AM, Tudor A, Zaharia LA.   +6 more
europepmc   +1 more source